UZ Leuven Lung Transplant Team utilized controlled hypothermic preservation provided by LUNGguard to preserve lungs between 4 and 8ºC, enabling next day recipient surgeryCAMBRIDGE, MASSACHUSETTS – February 8, 2023 -…
First use of Advanced Organ Preservation (AOP) technology in Hawaii allows donor lungs and liver to be successfully transported over 2300 miles CAMBRIDGE, MASSACHUSETTS – December 6, 2022 - Paragonix…
Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, MASSACHUSETTS – August 17, 2022 - Paragonix Technologies, Inc. is announcing a…
With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant CongressCAMBRIDGE, MASSACHUSETTS – Paragonix…
CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to…
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Paragonix Technologies Inc.today announced clearance of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Donor Lung Preservation System - LUNGguard1,2.The Paragonix LUNGguard…
Paragonix Technologies, Inc. today announced that the first series of pediatric donor hearts preserved and transported using Paragonix SherpaPak Cardiac Transport System occurred at University of Florida Health (UF Health) and Le Bonheur Children's Hospital (TN). Starting in Q1 2019, Paragonix SherpaPak™ CTS have been shipped with heart connectors covering most aortic diameters, permitting the anchoring of variously sized hearts, including small pediatric hearts, to its proprietary suspension system for improved donor heart transport.
Paragonix Technologies, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Paragonix SherpaPak™ Pancreas Transport System (PTS). Starting immediately, the Paragonix SherpaPak™ PTS will be commercially available to pancreas transplant centers and Organ Procurement Organizations. The Paragonix SherpaPak PTS provides unprecedented thermal and physical protection to the donor pancreas during transport from donor to recipient patients.
DURHAM, N.C.--(BUSINESS WIRE)-Duke University Hospital has transported its first donor heart using the only commercially available FDA cleared and CE marked system for cold donor heart storage and transport. The…
CONTACT
Paragonix Technologies, Inc
222 Third Street
Suite 2242
Cambridge, Massachusetts 02142
info@paragonixtechnologies.com
© 2022 All Rights Reserved | L-294